Browsing Vall d'Hebron Institut d'Oncologia - VHIO by Title
Now showing items 1-20 of 775
-
1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test
(Nature Research, 2020-10-20) -
2023 GEIS Guidelines for gastrointestinal stromal tumors
(SAGE Publications, 2023) -
30-Day Mortality Following Palliative Radiotherapy
(Frontiers Media, 2021-04-23) -
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
(Nature Research, 2021-02-17) -
A framework for artificial intelligence in cancer research and precision oncology
(Nature Portfolio, 2023-05-17) -
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
(American Society of Hematology, 2022-11-08) -
A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer
(Nature Research, 2020-04) -
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
(American Association for Cancer Research, 2022-06-01) -
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors
(American Association for Cancer Research, 2023-09-14) -
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer
(American Association for Cancer Research, 2023-01-17)